secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001104659-23-071187
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron shareholders re-elect all four Class II directors; bylaw amended to allow Co-Chairs
--------------------------------------------------------------------------------

- Joseph Goldstein, Christine Poon, Craig Thompson, Huda Zoghbi elected as Class II directors at June 9 annual meeting.
- Say-on-pay advisory vote approved (97.8M for, 14.5M against).
- Shareholders selected one-year frequency for future say-on-pay votes (111.2M votes).
- Non-binding proposal on access-to-medicine report rejected (10.6M for, 101.4M against).
- Bylaw amended to permit Board to elect two Co-Chairs, either of whom can exercise full powers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465923071187/0001104659-23-071187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465923071187/tm2318622d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-071187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer